1 Number with incontinence not improved (women's observations) |
1 |
|
Risk Ratio (M‐H, Fixed, 95% CI) |
Totals not selected |
1.1 oestradiol ring vs oestriol pessary |
1 |
|
Risk Ratio (M‐H, Fixed, 95% CI) |
0.0 [0.0, 0.0] |
2 Number of women with nocturia |
1 |
|
Risk Ratio (M‐H, Fixed, 95% CI) |
Totals not selected |
2.1 oestradiol ring vs oestriol pessary |
1 |
|
Risk Ratio (M‐H, Fixed, 95% CI) |
0.0 [0.0, 0.0] |
3 Number of women with dysuria |
1 |
|
Risk Ratio (M‐H, Fixed, 95% CI) |
Totals not selected |
3.1 oestradiol ring vs oestriol pessary |
1 |
|
Risk Ratio (M‐H, Fixed, 95% CI) |
0.0 [0.0, 0.0] |
4 Number of women with urgency |
1 |
|
Risk Ratio (M‐H, Fixed, 95% CI) |
Totals not selected |
4.1 oestradiol ring vs oestriol pessary |
1 |
|
Risk Ratio (M‐H, Fixed, 95% CI) |
0.0 [0.0, 0.0] |
4.2 oestrogen cream vs vaginal oestrogen + progesterone |
0 |
|
Risk Ratio (M‐H, Fixed, 95% CI) |
0.0 [0.0, 0.0] |
5 Number of women with frequency |
1 |
|
Risk Ratio (M‐H, Fixed, 95% CI) |
Totals not selected |
5.1 oestradiol ring vs oestriol pessary |
1 |
|
Risk Ratio (M‐H, Fixed, 95% CI) |
0.0 [0.0, 0.0] |
5.2 oestrogen cream vs vaginal oestrogen + progesterone |
0 |
|
Risk Ratio (M‐H, Fixed, 95% CI) |
0.0 [0.0, 0.0] |
6 Number of adverse events |
1 |
|
Risk Ratio (M‐H, Fixed, 95% CI) |
Totals not selected |
6.1 oestradiol ring vs oestriol pessary |
1 |
|
Risk Ratio (M‐H, Fixed, 95% CI) |
0.0 [0.0, 0.0] |